Overview

One-year post-developments in Clinical Trials Regulation (CTR), join us to assess the impact on timelines, alleviate concerns about potential delays, and gain insights into ongoing progress. This event provides a platform for shared experiences, live testimonials, and expert insights, ensuring you are well-equipped to make informed decisions that propel your early phase programs forward.

Objective

By attending this webinar, you will gain insight into the following:

• A comprehensive understanding of CTR and their impact on project timelines and RFI’s
• Practical implications '1 year later' through data-driven insights from SGS’s clinical pharmacology unit in Belgium
• Hear live testimonials from industry experts at Boehringer Ingelheim, navigating new regulations firsthand
• Understand how experiences from industry leaders influence decision-making when choosing countries for early phase programs
• Uncover actionable strategies for informed decision-making in early phase clinical trials

Agenda

• Introduction
• Impact on timelines and requests for information (RFI): unveiling one-year data 
• Live customer testimonials: real experiences, real insights
• Strategies for success: navigating the future of early phase clinical trials
• Q&A session: engage with experts, clarify your concerns, share experiences

Target Audience: The webinar is aimed at all professionals that are involved in clinical trial planning, regulatory compliance, country feasibility and strategic decision-making, such as COO, CSO, clinical operations managers, clinical project managers, procurement professionals or clinical research directors.

Language: English

Can't make a live session? Register now and receive a complimentary recording after the live event. For further information, please contact: healthscience@sgs.com